Cocrystal Pharma, Inc. Quarterly Common Stock, Shares Authorized from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Cocrystal Pharma, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2010 to Q3 2024.
  • Cocrystal Pharma, Inc. Common Stock, Shares Authorized for the quarter ending September 30, 2024 was 100M shares, a 33.3% decline year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 100M -50M -33.3% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 100M -50M -33.3% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 150M 0 0% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 150M 0 0% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 150M 0 0% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 150M 0 0% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 150M 0 0% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 150M 0 0% Dec 31, 2022 10-K 2024-03-28
Q3 2022 150M 0 0% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 150M +50M +50% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 150M +50M +50% Mar 31, 2022 10-Q 2022-05-11
Q4 2021 150M +50M +50% Dec 31, 2021 10-K 2023-03-29
Q3 2021 150M +50M +50% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 100M 0 0% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 100M 0 0% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 100M 0 0% Dec 31, 2020 10-K 2022-03-23
Q3 2020 100M 0 0% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 100M 0 0% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 100M 0 0% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 100M 0 0% Dec 31, 2019 10-K 2021-03-17
Q3 2019 100M 0 0% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 100M -700M -87.5% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 100M -700M -87.5% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 100M -700M -87.5% Dec 31, 2018 10-K 2020-03-27
Q3 2018 100M -700M -87.5% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 800M 0 0% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 800M 0 0% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 800M 0 0% Dec 31, 2017 10-K 2019-04-01
Q3 2017 800M 0 0% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 800M 0 0% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 800M +799M +99900% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 800M 0 0% Dec 31, 2016 10-K 2018-03-21
Q3 2016 800M 0 0% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 800M 0 0% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 800K -799M -99.9% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 800M +800M +399900% Dec 31, 2015 10-K 2017-03-31
Q3 2015 800M +800M +399900% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 800M +800M +399900% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 800M +800M +399900% Mar 31, 2015 10-Q 2015-05-14
Q4 2014 200K -62.2K -23.7% Dec 31, 2014 10-K 2016-03-15
Q3 2014 200K -99.8M -99.8% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 200K -99.8M -99.8% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 200K -99.8M -99.8% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 262K -2B -100% Dec 31, 2013 10-K 2015-03-31
Q3 2013 100M 0 0% Sep 30, 2013 10-Q 2013-11-18
Q2 2013 100M 0 0% Jun 30, 2013 10-Q 2013-08-15
Q1 2013 100M 0 0% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 2B +1.9B +1900% Dec 31, 2012 10-K 2014-03-31
Q3 2012 100M 0 0% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 100M 0 0% Jun 30, 2012 10-Q/A 2012-09-28
Q1 2012 100M Mar 31, 2012 10-Q/A 2012-10-02
Q4 2011 100M 0 0% Dec 31, 2011 10-K 2013-04-01
Q3 2011 100M Sep 30, 2011 10-Q 2011-11-21
Q2 2011 100M Jun 30, 2011 10-Q/A 2011-09-09
Q4 2010 100M Dec 31, 2010 10-K 2012-04-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.